PRCT
Healthcare Medical DevicesPROCEPT BioRobotics Corporation
$18.02
+0.22 +1.24% today Live
Price History
Not enough data
| Date | Price |
|---|---|
| Oct 7, 2026, live at 10:48 AM ET | 18.02 |
Key Stats
Market Cap
1.03B
Avg Volume
1.46M
EPS
-$1.94
52W High
$38.11
52W Low
$16.67
Div. Yield
0.0%
Analyst Ratings
Hold1
Str Buy
3
Buy
9
Hold
0
Sell
1
Str Sell
Valuation
Forward P/E
-15.63
P/B Ratio
3.03
P/S Ratio
3.06
EV/EBITDA
-7.74
EV/Revenue
2.53
Margins
Gross Margin 63.4%
Operating Margin (32.1%)
Net Margin (32.5%)
EBITDA Margin (32.6%)
Growth & Returns
Revenue Growth (YoY)
19.3%
Return on Equity
(30.2%)
Return on Assets
(14.8%)
Liquidity & Leverage
Current Ratio
6.55
Quick Ratio
5.23
Debt / Equity
0.23
Total Cash
227.91M
Total Debt
77.50M
About
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
www.procept-biorobotics.com